News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>UBS Rates CHINA LIFE as Buy; 1Q New Biz Value Surges 76%, Far Above Forecasts
According to a UBS research report, CHINA LIFE (02628.HK) posted a 1Q26 net profit after tax of RMB20 billion, down 32% YoY, mainly due to weak equity market performance in 1Q26 an...
Reset
Send
The window will close in 5 seconds
<Research>UBS Rates CHINA LIFE as Buy; 1Q New Biz Value Surges 76%, Far Above Forecasts
Close
Recommend
10
Positive
14
Negative
11
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get Level 1 Real-Time Streaming!

According to a UBS research report, CHINA LIFE (02628.HK)  -0.620 (-2.027%)    Short selling $352.42M; Ratio 22.781%   posted a 1Q26 net profit after tax of RMB20 billion, down 32% YoY, mainly due to weak equity market performance in 1Q26 and the company's relatively higher investment leverage. Despite its significance, this decline was broadly in line with market expectations.

On the bright side, CHINA LIFE's new business value surged by 76% YoY, far exceeding peers and investor expectations. UBS maintained a Buy rating on CHINA LIFE, with a target price of HKD40.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-13 16:25.)

Related News Daiwa: 2026 Mainland Corporate Earnings Recovery May Accelerate but Not Broad-Based

Auto-translated by AI
View Original Text
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.